User Reviews for Pralatrexate
Also known as: Folotyn
Pralatrexate has an average rating of 1.0 out of 10 from a total of 1 ratings on Drugs.com. 0% of those users who reviewed Pralatrexate reported a positive effect, while 100% reported a negative effect.
| Condition | Avg. Rating | Reviews | Compare | |
|---|---|---|---|---|
| Peripheral T-cell Lymphoma | 1.0 | 1 reviews | 3 medications | |
| Summary of Pralatrexate reviews | 1.0 | 1 reviews | ||
Reviews may be moderated or edited before publication to correct grammar and spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest in the medication will not be published. As reviews and ratings are subjective and self-reported, this information should not be used as the basis for any statistical analysis or scientific studies.
This information is NOT intended to endorse any particular medication. While these reviews might be helpful, they are not a substitute for the expertise, knowledge and judgement of healthcare practitioners.
More about pralatrexate
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Interactions
- En Español
- Drug class: antimetabolites
Consumer resources
- Other brands
- Folotyn
Folotyn (pralatrexate) for Peripheral T-cell Lymphoma: “My wife had two weekly treatments and developed a high fever, low blood counts, weakness, and confusion and was unable to continue. 15 days in the hospital to come back to previous condition. As there were other issues involved Folotyn was not determined to be the sole cause of her problems. We waited 9 weeks and tried another treatment of Folotyn, one week later we were back in the hospital for 12 days. This has not been a viable treatment for her as it has also had no effect on her PTCL NOS. We will most likely be trying Istodax next.”